SVA Life Sciences, a division of SVA Consulting, is featured in the November 2022 edition of Pharma Tech Outlook magazine.
In the issue’s cover story, the firm is highlighted for their work in helping life sciences companies through their commercialization roadmap. The launch of a product is the most critical and vulnerable point in its life cycle. By acknowledging and understanding the most pressing questions an organization has leading up to the first product launch, SVA Life Sciences helps biopharmaceutical companies plan and execute the launch of their product and the company that supports it.
Andrew DeMarco, Commercialization Strategist and Principal, sums it up best: “We believe if you just do the right thing by helping people and solving their problems, at the end of the day…it will benefit you.” And that is SVA Life Sciences’ philosophy and core goal to Serve People Better.
To read the entire story, visit Pharma Tech Outlook’s website.
© 2022 SVA Life Sciences
